Advances in Hematological Malignancies
Recent years have witnessed remarkable advancements in the field of hematological malignancies. Novel treatment modalities such as targeted agents, immunotherapies, and gene editing are transforming the prognosis for patients with blood cancers. Clinical trials continue to explore these innovative techniques, offering hope for more successful treat